imu-131
imugene
[]
 her-vaxx &amp; ctx vs ctx in her2+ pts with gastric/gej adenocarcinoma @ asco-gi 2023 herizon phs-ii, 39 pts mos 13.9 vs 8.3 mo, mpfs 6.9 vs 6 dor 30 vs 19 weeks control arm not soc, recruitment in india/eastern europe should/can we add io? 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine